GTC Biotherapeutics (fka GTCB)

[oldacct]

I also fear this will happen.

I was an original investor in Genzyme and feel quite
familiar with Henri Termeer. In the early 90's he spent
half the annual meeting discussing GTC and its' future
in addition to showing a 20 minute video before the meeting.
It has been my feeling that he would wait until the use
of transgenics is approved (Atryn)before he would act on
bringing GTC back into the parent company. Genzyme
divested itself of GTC in order to clean up their income
statement to meet earnings projections.

My feeling is analyst Phil Nadeau of Cowen stopped following
GTC because he knows there will be no further financing
before Genzyme decides whether to take on GTC.

Genzyme did this with Biosurgery which was a tracking stock unlike GTC.